CAS: 2505001-62-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | (E)-3-(3,4-Dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide REF: AN-AG01XBU4CAS: 2505001-62-5 | 98% | To inquire | Mon 22 Jul 24 |
 | SR18662 free base REF: TM-T9307CAS: 2505001-62-5 | 98.16% | 48.00 €~1,425.00 € | Mon 29 Jul 24 |
(E)-3-(3,4-Dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide
CAS:2505001-62-5
Formula:
C16H19Cl2N3O4S
Purity:
98%
Molecular weight:
420.3108
Ref: AN-AG01XBU4
| 5mg | 140.00 € | ||
| 10mg | 163.00 € | ||
| 25mg | 182.00 € | ||
| 50mg | 289.00 € | ||
| 100mg | 487.00 € | ||
| 500mg | To inquire |
Estimated delivery in United States, on Monday 22 Jul 2024
SR18662 free base
CAS:2505001-62-5
SR18662, a KLF5 inhibitor derived from ML264, blocks colorectal cancer growth.
Formula:
C16H19Cl2N3O4S
Purity:
98.16%
Color and Shape:
Solid
Molecular weight:
420.31
Ref: TM-T9307
| 1mg | 48.00 € | ||
| 1ml | 95.00 € | ||
| 5mg | 94.00 € | ||
| 10mg | 157.00 € | ||
| 25mg | 306.00 € | ||
| 50mg | 494.00 € | ||
| 100mg | 705.00 € | ||
| 500mg | 1,425.00 € |
Estimated delivery in United States, on Monday 29 Jul 2024
